Biocomposites is an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, South America, USA, Canada, China and India. In January 2026 Biocomposites was named as one of the UK’s 100 fastest growing technology companies by The Sunday Times. Biocomposites, Inc. is its Wilmington, North Carolina based subsidiary that supports Biocomposites activities in the Americas.

In the US, there are around 1.6m people who have a diabetic foot infection, with a 5.6 times higher chance of requiring an amputation. Studies further indicate that following a major amputation 50% of amputees will only survive for a further 2 years. As part of its ongoing investment into R & D, Biocomposites has commenced a phase III clinical study for a new drug that will transform the way healthcare professionals treat diabetic foot osteomyelitis.

A team is being assembled to prepare for the launch of this new drug (followed by additional new drugs) into the US healthcare market. The Director of Market Access will play a mission-critical role in shaping and executing all U.S. market access activities required for a successful launch and sustained post-launch uptake.

Key Responsibilities

Coding, Reimbursement & Policy Readiness

• Evaluate coding pathways (CPT/HCPCS/ICD10-PCS) and secure new codes if needed.
• Map reimbursement pathways and identify friction points.
• Evaluate and secure reimbursement codes (NTAP/ TPT/J-code)
• Partner with Government Affairs for CMS and policy readiness.
• Prepare coverage policy submission strategy.

Pre-Launch Market Access Strategy

• Develop U.S. market access launch blueprint including pricing, contracting, coding, payer engagement, and evidence requirements.
• Conduct payer landscape analysis to understand anticipated coverage barriers.
• Build the payer value proposition framework.
• Lead development of payer tools including dossiers and economic models.

Evidence Strategy & Health Economic and Outcomes Research (HEOR) Integration

• Define payer-relevant evidence needs with HEOR and Medical Affairs.
• Influence clinical trial design for payer-relevant outcomes.
• Identify and close evidence gaps.

National Payer & Health System Engagement

• Conduct pre-approval engagements with national payers, GPOs and IDNs.
• Lead payer advisory boards.
• Develop launch-day payer engagement plans.

Data, Analytics & Forecasting

• Provide inputs for launch plan and pricing scenarios.
• Use claims and analog data for forecasting.
• Track KPIs including coverage decisions and formulary wins.

Launch Leadership

• Align payer insights with Marketing, Medical, Sales.
• Prepare field teams for reimbursement discussions.
• Provide field teams with messaging and tools to support launch.

Qualifications

• 8+ years of pharmaceutical U.S. Market Access experience including pre-launch.
• Strong coding, reimbursement, payer strategy expertise.
• Proven track record in leading the reimbursement activities for the launch of a new drug, including J-code/NTAP/TPT submissions
• Experience with leading reimbursement activities in both hospital and ASC/outpatient environments.
• Experience in specialty therapeutics, biologics, or hospital-administered products.
• Exceptional communication, analytical and negotiation skills.
• Bachelor’s degree required; advanced degree preferred.